The Genetic Evolution of Melanoma from Precursor Lesions von Shain, A. Hunter, Yeh, Iwei, Kovalyshyn, Ivanka, Sriharan, Aravindhan, Talevich, Eric, Gagnon, Alexander, Dummer, Reinhard, North, Jeffrey, Pincus, Laura, Ruben, Beth, Rickaby, William, D’Arrigo, Corrado, Robson, Alistair, Bastian, Boris C

Volltext

Development of encorafenib for BRAF-mutated advanced melanoma von Koelblinger, Peter, Thuerigen, Olaf, Dummer, Reinhard

Volltext

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy von Krieg, Carsten, Nowicka, Malgorzata, Guglietta, Silvia, Schindler, Sabrina, Hartmann, Felix J, Weber, Lukas M, Dummer, Reinhard, Robinson, Mark D, Levesque, Mitchell P, Becher, Burkhard

Volltext

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma von Long, Georgina V, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Schadendorf, Dirk, Lesimple, Thierry, Plummer, Ruth, Ji, Ran, Zhang, Pingkuan, Mookerjee, Bijoyesh, Legos, Jeff, Kefford, Richard, Dummer, Reinhard, Kirkwood, John M

Volltext

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma von Delord, Jean-Pierre, Robert, Caroline, Nyakas, Marta, McArthur, Grant A, Kudchakar, Ragini, Mahipal, Amit, Yamada, Yasuhide, Sullivan, Ryan, Arance, Ana, Kefford, Richard F, Carlino, Matteo S, Hidalgo, Manuel, Gomez-Roca, Carlos, Michel, Daniela, Seroutou, Abdelkader, Aslanis, Vassilios, Caponigro, Giordano, Stuart, Darrin D, Moutouh-de Parseval, Laure, Demuth, Tim, Dummer, Reinhard

Volltext

Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy von Goldinger, Simone M, Stieger, Pascale, Meier, Barbara, Micaletto, Sara, Contassot, Emmanuel, French, Lars E, Dummer, Reinhard

Volltext

Ultraviolet A and Photosensitivity during Vemurafenib Therapy von Dummer, Reinhard, Rinderknecht, Jeannine, Goldinger, Simone M

Volltext

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind st... von Long, Georgina V, Prof, Dummer, Reinhard, Prof, Hamid, Omid, MD, Gajewski, Thomas F, Prof, Caglevic, Christian, MD, Dalle, Stephane, Prof, Arance, Ana, MD, Carlino, Matteo S, PhD, Grob, Jean-Jacques, Prof, Kim, Tae Min, Prof, Demidov, Lev, Prof, Robert, Caroline, Prof, Larkin, James, Prof, Anderson, James R, PhD, Maleski, Janet, BSN, Jones, Mark, MD, Diede, Scott J, MD, Mitchell, Tara C, MD

Volltext

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib von Robert, Caroline, Karaszewska, Boguslawa, Schachter, Jacob, Rutkowski, Piotr, Mackiewicz, Andrzej, Stroiakovski, Daniil, Lichinitser, Michael, Dummer, Reinhard, Grange, Florent, Mortier, Laurent, Chiarion-Sileni, Vanna, Drucis, Kamil, Krajsova, Ivana, Hauschild, Axel, Lorigan, Paul, Wolter, Pascal, Long, Georgina V, Flaherty, Keith, Nathan, Paul, Ribas, Antoni, Martin, Anne-Marie, Sun, Peng, Crist, Wendy, Legos, Jeff, Rubin, Stephen D, Little, Shonda M, Schadendorf, Dirk

Volltext

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines von Peris, Ketty, Fargnoli, Maria Concetta, Garbe, Claus, Kaufmann, Roland, Bastholt, Lars, Seguin, Nicole Basset, Bataille, Veronique, Marmol, Veronique del, Dummer, Reinhard, Harwood, Catherine A., Hauschild, Axel, Höller, Christoph, Haedersdal, Merete, Malvehy, Josep, Middleton, Mark R., Morton, Colin A., Nagore, Eduardo, Stratigos, Alexander J., Szeimies, Rolf-Markus, Tagliaferri, Luca, Trakatelli, Myrto, Zalaudek, Iris, Eggermont, Alexander, Grob, Jean Jacques

Volltext

The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemur... von Dummer, Reinhard, Welti, Michèle, Ramelyte, Egle

Volltext

Toward Minimal Residual Disease-Directed Therapy in Melanoma von Rambow, Florian, Rogiers, Aljosja, Marin-Bejar, Oskar, Aibar, Sara, Femel, Julia, Dewaele, Michael, Karras, Panagiotis, Brown, Daniel, Chang, Young Hwan, Debiec-Rychter, Maria, Adriaens, Carmen, Radaelli, Enrico, Wolter, Pascal, Bechter, Oliver, Dummer, Reinhard, Levesque, Mitchell, Piris, Adriano, Frederick, Dennie T., Boland, Genevieve, Flaherty, Keith T., van den Oord, Joost, Voet, Thierry, Aerts, Stein, Lund, Amanda W., Marine, Jean-Christophe

Volltext

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma von Van Allen, Eliezer M., Miao, Diana, Schilling, Bastian, Shukla, Sachet A., Blank, Christian, Zimmer, Lisa, Sucker, Antje, Hillen, Uwe, Foppen, Marnix H. Geukes, Goldinger, Simone M., Utikal, Jochen, Hassel, Jessica C., Weide, Benjamin, Kaehler, Katharina C., Loquai, Carmen, Mohr, Peter, Gutzmer, Ralf, Dummer, Reinhard, Gabriel, Stacey, Wu, Catherine J., Schadendorf, Dirk, Garraway, Levi A.

Volltext

Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective von Ramelyte, Egle, Tastanova, Aizhan, Balázs, Zsolt, Ignatova, Desislava, Turko, Patrick, Menzel, Ulrike, Guenova, Emmanuella, Beisel, Christian, Krauthammer, Michael, Levesque, Mitchell Paul, Dummer, Reinhard

Volltext

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study von Meric-Bernstam, Funda, Sweis, Randy F, Kasper, Stefan, Hamid, Omid, Bhatia, Shailender, Dummer, Reinhard, Stradella, Agostina, Long, Georgina V, Spreafico, Anna, Shimizu, Toshio, Steeghs, Neeltje, Luke, Jason J, McWhirter, Sarah M, Müller, Thomas, Nair, Nitya, Lewis, Nancy, Chen, Xinhui, Bean, Andrew, Kattenhorn, Lisa, Pelletier, Marc, Sandhu, Shahneen

Volltext

Immunological effects of BRAF+MEK inhibition von Ascierto, Paolo A., Dummer, Reinhard

Volltext

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe von Dimitriou, Florentia, Krattinger, Regina, Ramelyte, Egle, Barysch, Marjam J., Micaletto, Sara, Dummer, Reinhard, Goldinger, Simone M.

Volltext

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial von Ribas, Antoni, Prof, Puzanov, Igor, MD, Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Hamid, Omid, MD, Robert, Caroline, Prof, Hodi, F Stephen, MD, Schachter, Jacob, Prof, Pavlick, Anna C, MD, Lewis, Karl D, MD, Cranmer, Lee D, MD, Blank, Christian U, MD, O'Day, Steven J, MD, Ascierto, Paolo A, Prof, Salama, April K S, MD, Margolin, Kim A, Prof, Loquai, Carmen, MD, Eigentler, Thomas K, MD, Gangadhar, Tara C, MD, Carlino, Matteo S, MBBS, Agarwala, Sanjiv S, Prof, Moschos, Stergios J, MD, Sosman, Jeffrey A, Prof, Goldinger, Simone M, MD, Shapira-Frommer, Ronnie, MD, Gonzalez, Rene, Prof, Kirkwood, John M, Prof, Wolchok, Jedd D, Prof, Eggermont, Alexander, Prof, Li, Xiaoyun Nicole, PhD, Zhou, Wei, PhD, Zernhelt, Adriane M, BS, Lis, Joy, BSN, Ebbinghaus, Scot, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial von Eggermont, Alexander M M, Prof, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Céleste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Konto, Cyril, MD, Hoos, Axel, MD, de Pril, Veerle, MSc, Gurunath, Ravichandra Karra, MD, de Schaetzen, Gaetan, PhD, Suciu, Stefan, PhD, Testori, Alessandro, MD

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext